Gene Therapy For Cancer Market, Global Outlook and Forecast 2022-2028

January 2022 | 64 pages | ID: GDCBDB67D222EN
Market Monitor Global

Abstracts

The transshipment company is a third-party logistics company, mostly with the function of collecting and forwarding. The quality of a transshipment company mainly depends on its own internal management and the strength of the logistics company that it cooperates with.

This report contains market size and forecasts of International Express Delivery Service in Global, including the following market information:

Global International Express Delivery Service Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global International Express Delivery Service market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Air Transshipment Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of International Express Delivery Service include SCS EXpress, Fedex, TNT Express, UPS, TWILL, Buy And Ship, EWEUS, Trans Rush and Ausuyan and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the International Express Delivery Service companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global International Express Delivery Service Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global International Express Delivery Service Market Segment Percentages, by Type, 2021 (%)

• Air Transshipment
• Land Transfer
• Ship Transfer
• Other

Global International Express Delivery Service Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global International Express Delivery Service Market Segment Percentages, by Application, 2021 (%)

• Overseas Shopping
• International Express
• Other

Global International Express Delivery Service Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global International Express Delivery Service Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies International Express Delivery Service revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies International Express Delivery Service revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• SCS EXpress
• Fedex
• TNT Express
• UPS
• TWILL
• Buy And Ship
• EWEUS
• Trans Rush
• Ausuyan
• UUCH

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Gene Therapy For Cancer Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Gene Therapy For Cancer Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL GENE THERAPY FOR CANCER OVERALL MARKET SIZE

2.1 Global Gene Therapy For Cancer Market Size: 2021 VS 2028
2.2 Global Gene Therapy For Cancer Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Gene Therapy For Cancer Players in Global Market
3.2 Top Global Gene Therapy For Cancer Companies Ranked by Revenue
3.3 Global Gene Therapy For Cancer Revenue by Companies
3.4 Top 3 and Top 5 Gene Therapy For Cancer Companies in Global Market, by Revenue in 2021
3.5 Global Companies Gene Therapy For Cancer Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gene Therapy For Cancer Players in Global Market
  3.6.1 List of Global Tier 1 Gene Therapy For Cancer Companies
  3.6.2 List of Global Tier 2 and Tier 3 Gene Therapy For Cancer Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Gene Therapy For Cancer Market Size Markets, 2021 & 2028
  4.1.2 Rb Gene
  4.1.3 P53 Gene
  4.1.4 APC Gene
  4.1.5 NF1 Gene
  4.1.6 Others
4.2 By Type - Global Gene Therapy For Cancer Revenue & Forecasts
  4.2.1 By Type - Global Gene Therapy For Cancer Revenue, 2017-2022
  4.2.2 By Type - Global Gene Therapy For Cancer Revenue, 2023-2028
  4.2.3 By Type - Global Gene Therapy For Cancer Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Gene Therapy For Cancer Market Size, 2021 & 2028
  5.1.2 Cancer Treatment
  5.1.3 Tissue Repair
  5.1.4 Others
5.2 By Application - Global Gene Therapy For Cancer Revenue & Forecasts
  5.2.1 By Application - Global Gene Therapy For Cancer Revenue, 2017-2022
  5.2.2 By Application - Global Gene Therapy For Cancer Revenue, 2023-2028
  5.2.3 By Application - Global Gene Therapy For Cancer Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Gene Therapy For Cancer Market Size, 2021 & 2028
6.2 By Region - Global Gene Therapy For Cancer Revenue & Forecasts
  6.2.1 By Region - Global Gene Therapy For Cancer Revenue, 2017-2022
  6.2.2 By Region - Global Gene Therapy For Cancer Revenue, 2023-2028
  6.2.3 By Region - Global Gene Therapy For Cancer Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Gene Therapy For Cancer Revenue, 2017-2028
  6.3.2 US Gene Therapy For Cancer Market Size, 2017-2028
  6.3.3 Canada Gene Therapy For Cancer Market Size, 2017-2028
  6.3.4 Mexico Gene Therapy For Cancer Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Gene Therapy For Cancer Revenue, 2017-2028
  6.4.2 Germany Gene Therapy For Cancer Market Size, 2017-2028
  6.4.3 France Gene Therapy For Cancer Market Size, 2017-2028
  6.4.4 U.K. Gene Therapy For Cancer Market Size, 2017-2028
  6.4.5 Italy Gene Therapy For Cancer Market Size, 2017-2028
  6.4.6 Russia Gene Therapy For Cancer Market Size, 2017-2028
  6.4.7 Nordic Countries Gene Therapy For Cancer Market Size, 2017-2028
  6.4.8 Benelux Gene Therapy For Cancer Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Gene Therapy For Cancer Revenue, 2017-2028
  6.5.2 China Gene Therapy For Cancer Market Size, 2017-2028
  6.5.3 Japan Gene Therapy For Cancer Market Size, 2017-2028
  6.5.4 South Korea Gene Therapy For Cancer Market Size, 2017-2028
  6.5.5 Southeast Asia Gene Therapy For Cancer Market Size, 2017-2028
  6.5.6 India Gene Therapy For Cancer Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Gene Therapy For Cancer Revenue, 2017-2028
  6.6.2 Brazil Gene Therapy For Cancer Market Size, 2017-2028
  6.6.3 Argentina Gene Therapy For Cancer Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Gene Therapy For Cancer Revenue, 2017-2028
  6.7.2 Turkey Gene Therapy For Cancer Market Size, 2017-2028
  6.7.3 Israel Gene Therapy For Cancer Market Size, 2017-2028
  6.7.4 Saudi Arabia Gene Therapy For Cancer Market Size, 2017-2028
  6.7.5 UAE Gene Therapy For Cancer Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 GLIEAD
  7.1.1 GLIEAD Corporate Summary
  7.1.2 GLIEAD Business Overview
  7.1.3 GLIEAD Gene Therapy For Cancer Major Product Offerings
  7.1.4 GLIEAD Gene Therapy For Cancer Revenue in Global Market (2017-2022)
  7.1.5 GLIEAD Key News
7.2 REGENXBIO
  7.2.1 REGENXBIO Corporate Summary
  7.2.2 REGENXBIO Business Overview
  7.2.3 REGENXBIO Gene Therapy For Cancer Major Product Offerings
  7.2.4 REGENXBIO Gene Therapy For Cancer Revenue in Global Market (2017-2022)
  7.2.5 REGENXBIO Key News
7.3 Autolus
  7.3.1 Autolus Corporate Summary
  7.3.2 Autolus Business Overview
  7.3.3 Autolus Gene Therapy For Cancer Major Product Offerings
  7.3.4 Autolus Gene Therapy For Cancer Revenue in Global Market (2017-2022)
  7.3.5 Autolus Key News
7.4 American Gene Technologies
  7.4.1 American Gene Technologies Corporate Summary
  7.4.2 American Gene Technologies Business Overview
  7.4.3 American Gene Technologies Gene Therapy For Cancer Major Product Offerings
  7.4.4 American Gene Technologies Gene Therapy For Cancer Revenue in Global Market (2017-2022)
  7.4.5 American Gene Technologies Key News
7.5 Arcellx
  7.5.1 Arcellx Corporate Summary
  7.5.2 Arcellx Business Overview
  7.5.3 Arcellx Gene Therapy For Cancer Major Product Offerings
  7.5.4 Arcellx Gene Therapy For Cancer Revenue in Global Market (2017-2022)
  7.5.5 Arcellx Key News
7.6 AUSTRIANOVA
  7.6.1 AUSTRIANOVA Corporate Summary
  7.6.2 AUSTRIANOVA Business Overview
  7.6.3 AUSTRIANOVA Gene Therapy For Cancer Major Product Offerings
  7.6.4 AUSTRIANOVA Gene Therapy For Cancer Revenue in Global Market (2017-2022)
  7.6.5 AUSTRIANOVA Key News
7.7 Alphavax
  7.7.1 Alphavax Corporate Summary
  7.7.2 Alphavax Business Overview
  7.7.3 Alphavax Gene Therapy For Cancer Major Product Offerings
  7.7.4 Alphavax Gene Therapy For Cancer Revenue in Global Market (2017-2022)
  7.7.5 Alphavax Key News
7.8 Cellectis
  7.8.1 Cellectis Corporate Summary
  7.8.2 Cellectis Business Overview
  7.8.3 Cellectis Gene Therapy For Cancer Major Product Offerings
  7.8.4 Cellectis Gene Therapy For Cancer Revenue in Global Market (2017-2022)
  7.8.5 Cellectis Key News
7.9 Chimeron
  7.9.1 Chimeron Corporate Summary
  7.9.2 Chimeron Business Overview
  7.9.3 Chimeron Gene Therapy For Cancer Major Product Offerings
  7.9.4 Chimeron Gene Therapy For Cancer Revenue in Global Market (2017-2022)
  7.9.5 Chimeron Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Gene Therapy For Cancer Market Opportunities & Trends in Global Market
Table 2. Gene Therapy For Cancer Market Drivers in Global Market
Table 3. Gene Therapy For Cancer Market Restraints in Global Market
Table 4. Key Players of Gene Therapy For Cancer in Global Market
Table 5. Top Gene Therapy For Cancer Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Gene Therapy For Cancer Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Gene Therapy For Cancer Revenue Share by Companies, 2017-2022
Table 8. Global Companies Gene Therapy For Cancer Product Type
Table 9. List of Global Tier 1 Gene Therapy For Cancer Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gene Therapy For Cancer Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Gene Therapy For Cancer Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Gene Therapy For Cancer Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Gene Therapy For Cancer Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Gene Therapy For Cancer Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Gene Therapy For Cancer Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Gene Therapy For Cancer Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Gene Therapy For Cancer Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Gene Therapy For Cancer Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Gene Therapy For Cancer Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Gene Therapy For Cancer Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Gene Therapy For Cancer Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Gene Therapy For Cancer Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Gene Therapy For Cancer Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Gene Therapy For Cancer Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Gene Therapy For Cancer Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Gene Therapy For Cancer Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Gene Therapy For Cancer Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Gene Therapy For Cancer Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Gene Therapy For Cancer Revenue, (US$, Mn), 2023-2028
Table 30. GLIEAD Corporate Summary
Table 31. GLIEAD Gene Therapy For Cancer Product Offerings
Table 32. GLIEAD Gene Therapy For Cancer Revenue (US$, Mn), (2017-2022)
Table 33. REGENXBIO Corporate Summary
Table 34. REGENXBIO Gene Therapy For Cancer Product Offerings
Table 35. REGENXBIO Gene Therapy For Cancer Revenue (US$, Mn), (2017-2022)
Table 36. Autolus Corporate Summary
Table 37. Autolus Gene Therapy For Cancer Product Offerings
Table 38. Autolus Gene Therapy For Cancer Revenue (US$, Mn), (2017-2022)
Table 39. American Gene Technologies Corporate Summary
Table 40. American Gene Technologies Gene Therapy For Cancer Product Offerings
Table 41. American Gene Technologies Gene Therapy For Cancer Revenue (US$, Mn), (2017-2022)
Table 42. Arcellx Corporate Summary
Table 43. Arcellx Gene Therapy For Cancer Product Offerings
Table 44. Arcellx Gene Therapy For Cancer Revenue (US$, Mn), (2017-2022)
Table 45. AUSTRIANOVA Corporate Summary
Table 46. AUSTRIANOVA Gene Therapy For Cancer Product Offerings
Table 47. AUSTRIANOVA Gene Therapy For Cancer Revenue (US$, Mn), (2017-2022)
Table 48. Alphavax Corporate Summary
Table 49. Alphavax Gene Therapy For Cancer Product Offerings
Table 50. Alphavax Gene Therapy For Cancer Revenue (US$, Mn), (2017-2022)
Table 51. Cellectis Corporate Summary
Table 52. Cellectis Gene Therapy For Cancer Product Offerings
Table 53. Cellectis Gene Therapy For Cancer Revenue (US$, Mn), (2017-2022)
Table 54. Chimeron Corporate Summary
Table 55. Chimeron Gene Therapy For Cancer Product Offerings
Table 56. Chimeron Gene Therapy For Cancer Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Gene Therapy For Cancer Segment by Type in 2021
Figure 2. Gene Therapy For Cancer Segment by Application in 2021
Figure 3. Global Gene Therapy For Cancer Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Gene Therapy For Cancer Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Gene Therapy For Cancer Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Gene Therapy For Cancer Revenue in 2021
Figure 8. By Type - Global Gene Therapy For Cancer Revenue Market Share, 2017-2028
Figure 9. By Application - Global Gene Therapy For Cancer Revenue Market Share, 2017-2028
Figure 10. By Region - Global Gene Therapy For Cancer Revenue Market Share, 2017-2028
Figure 11. By Country - North America Gene Therapy For Cancer Revenue Market Share, 2017-2028
Figure 12. US Gene Therapy For Cancer Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Gene Therapy For Cancer Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Gene Therapy For Cancer Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Gene Therapy For Cancer Revenue Market Share, 2017-2028
Figure 16. Germany Gene Therapy For Cancer Revenue, (US$, Mn), 2017-2028
Figure 17. France Gene Therapy For Cancer Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Gene Therapy For Cancer Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Gene Therapy For Cancer Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Gene Therapy For Cancer Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Gene Therapy For Cancer Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Gene Therapy For Cancer Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Gene Therapy For Cancer Revenue Market Share, 2017-2028
Figure 24. China Gene Therapy For Cancer Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Gene Therapy For Cancer Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Gene Therapy For Cancer Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Gene Therapy For Cancer Revenue, (US$, Mn), 2017-2028
Figure 28. India Gene Therapy For Cancer Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Gene Therapy For Cancer Revenue Market Share, 2017-2028
Figure 30. Brazil Gene Therapy For Cancer Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Gene Therapy For Cancer Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Gene Therapy For Cancer Revenue Market Share, 2017-2028
Figure 33. Turkey Gene Therapy For Cancer Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Gene Therapy For Cancer Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Gene Therapy For Cancer Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Gene Therapy For Cancer Revenue, (US$, Mn), 2017-2028
Figure 37. GLIEAD Gene Therapy For Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. REGENXBIO Gene Therapy For Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Autolus Gene Therapy For Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. American Gene Technologies Gene Therapy For Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Arcellx Gene Therapy For Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. AUSTRIANOVA Gene Therapy For Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Alphavax Gene Therapy For Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Cellectis Gene Therapy For Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Chimeron Gene Therapy For Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)